As of Feb 21, 2025, Amedisys, Inc. Intrinsic Value is $85.0. This suggests it may be overvalued by 6.1% compared to its current price of around $90.4.

What is Amedisys, Inc. DCF (discounted cash flow) valuation?

As of Feb 21, 2025, Amedisys, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $90.4, using a discount rate of 7.2% and terminal growth rate of 3.0%.

Is Amedisys, Inc. overvalued or undervalued?

Amedisys, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $85.0, compared to a market price of around $90.4. This suggests a potential overvaluation of 6.1%.